Press Releases

The Harley Street Medical Area (HSMA) Healthcare Conference unites world-leading institutions to discuss the future of life science innovation in London

Harley Street Medical Area has announced its Healthcare Conference is taking place on Wednesday 19th October 2022.

DAMAN enters ambitious European precision medicine healthcare project

Daman Digital (DAMAN), a digital healthcare partner based in Denmark, has announced its part in the ambitious European precision medicine healthcare project, SQUEEZE.

DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE

Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) and is installing the largest commercial platform of the Olink® technology in the Americas outside of Olink itself to become a leading global certified service provider for the Olink Proximity Extension Assay (PEA) technology, a unique anti-body based proteomic technology.

Curebase and Meru Health to Partner on Clinical Research for App-based Mental Health Treatment Program

Curebase, a company committed to democratizing access to clinical studies, today announced it is partnering with Meru Health on a three-year clinical trial to determine the effectiveness of the online mental healthcare provider’s 12-week treatment program for reducing depression among primary care patients.

BioIVT Launches GMP-grade VivoSTART Leukopaks for Cell and Gene Therapy Manufacturing

VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.

Liposomes as Drug Delivery Vehicles

High-Quality Dexmedetomidine Hydrochloride (API) Meeting CP & EP Standards

Inizio Biotech makes key leadership appointment to meet demand from emerging biotech

Clinion - Platinum Sponsor for ISCR 3rd Autumn Conference 2022

Clinion is anticipating the world’s leading clinical research specialists to participate in the ISCR 3rd Autumn Conference, with the purpose of stepping into a brand-new era of clinical trial innovation! HICC, Novotel, Hyderabad, Telangana, India, 17 September 2022.

Biological Stains for Laboratory and Diagnostic Use

Graphene Modification Helps to Unlock New Potentials

Accelerated Shelf-Life Testing to Assess Drug Stability

Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals

BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates

XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies.

Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022

BOC Sciences August Promotion: Comprehensive Labeled Peptides with Stable Quality

As a pioneer in stable isotopic labeling chemistry, BOC Sciences develops a large variety of SIL compounds. Its promotion of labeled peptides, the increasingly used materials for convenient detection in research, is on the boil in August.

BOC Sciences Outlines Its Contribution of Peptides to Cardiovascular Research

BOC Sciences' monthly report released in August showed that its peptide products had vastly facilitated the R&D of cardiovascular therapies.

BOC Sciences August Promotion: Compound Docking Solutions for Drug Discovery

As the leading expert in computer-aided drug discovery, BOC Sciences has developed compound docking technologies to facilitate the discovery of novel ligands for over 30 targets.

BOC Sciences 2022 Free Webinar: Viral RNA Modifications and Implications for Novel Therapeutics

BioIVT Highlights ADME-Tox Research Advances at ISSX/MDO 2022

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, is highlighting recent ADME-Tox research at the 13th International Meeting of the International Society for the Study of Xenobiotics (ISSX) and 24th International Symposium on Microsomes and Drug Oxidations (MDO). This conference will be held from September 11-14 at the Westin Seattle.